Is Obinutuzumab a chemotherapy drug or a targeted drug?

Obinutuzumab is a targeted anticancer drug, a treatment for chronic lymphocytic leukemia and follicular lymphoma, also known by its brand name Gazyva. Before and during treatment, patients need blood tests. Doctors check your blood cell levels and other substances in your blood. They also check how well your liver and kidneys are working.

Otuzumab is a type of targeted cancer drug called a monoclonal antibody, which works by recognizing and finding specific proteins on cells. Otuzumabtargets a protein calledCD20 on the surface of lymphoma and leukemia cells. Otuzumabsticks to all CD20 proteins it finds, which makes it easier for the immune system's cells to pick out the tagged cells and kill them. Treatment cycles with otuzumab last 28 days (4 weeks), with a typical total of 6 cycles of treatment. The frequency and severity of otuzumab side effects vary from person to person, and they also depend on other treatments the person is receiving.

The original drug of Otuzumab has been launched in China and has entered the scope of medical insurance, but it is only reimbursed for patients who meet the indications. Specifications The price of 1000mg (40ml)*1 bottle may be around 9,000 yuan, which is a strictly controlled drug. The price of the Turkish version of Otuzumab Specifications1000mg/40ml per box listed overseas may be around RMB 10,000 (the price may fluctuate due to the exchange rate). The ingredients of the original drugs sold domestically and abroad are basically the same. There is currently no generic version of Otuzumab produced and launched. For more drug information and specific prices, please consult the medical consultant of Yaode.